Post by clarise on Mar 7, 2020 1:01:49 GMT -7
Below is a link to colloidal silver article. Here are some of the choice excerpts, it's rather intriguing what nanoparticles can do.
www.ncbi.nlm.nih.gov/pmc/articles/PMC6264685/#!po=13.7168
"Nanotechnologies have been used to develop nanoparticle-based targeted drug carriers [6,7], rapid pathogen detection [8,9], and biomolecular sensing [10], as well as nanoparticle-based cancer therapies [11,12]. The use of nanoparticles can be extended to the development of antivirals that act by interfering with viral infection, particularly during attachment and entry."
"The antibacterial activity of silver nanoparticles was mainly demonstrated by in vitro experiments. Activity against methicillin-resistant Staphylococcus aureus (MRSA) [23], Escherichia coli [4,21,24,25], Pseudomonas aeruginosa [4], Vibrio cholera [4] and Bacillus subtilis [25] has been documented. "
"recently some studies have emerged showing that metal nanoparticles can be effective antiviral agents against HIV-1 [37,38,39,40], hepatitis B virus [41], respiratory syncytial virus [42], herpes simplex virus type 1 [43,44], monkeypox virus [45], influenza virus [46] and Tacaribe virus [47]."
www.ncbi.nlm.nih.gov/pmc/articles/PMC6264685/#!po=13.7168
"Nanotechnologies have been used to develop nanoparticle-based targeted drug carriers [6,7], rapid pathogen detection [8,9], and biomolecular sensing [10], as well as nanoparticle-based cancer therapies [11,12]. The use of nanoparticles can be extended to the development of antivirals that act by interfering with viral infection, particularly during attachment and entry."
"The antibacterial activity of silver nanoparticles was mainly demonstrated by in vitro experiments. Activity against methicillin-resistant Staphylococcus aureus (MRSA) [23], Escherichia coli [4,21,24,25], Pseudomonas aeruginosa [4], Vibrio cholera [4] and Bacillus subtilis [25] has been documented. "
"recently some studies have emerged showing that metal nanoparticles can be effective antiviral agents against HIV-1 [37,38,39,40], hepatitis B virus [41], respiratory syncytial virus [42], herpes simplex virus type 1 [43,44], monkeypox virus [45], influenza virus [46] and Tacaribe virus [47]."
